guest ::
| Home > Publications Database > SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson's Disease Patients. |
| Home > Publications Database > SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson's Disease Patients. |
| Journal Article | DZNE-2022-01759 |
; ; ; ; ; ; ; ;
2022
Molecular Diversity Preservation International
Basel
This record in other databases: 
Please use a persistent id in citations: doi:10.3390/ijms232214166
Abstract: β-glucocerebrosidase (GBA)-associated mutations are a significant risk factor for Parkinson's disease (PD) that aggravate the disease pathology by upregulating the deposition of α-Synuclein (α-Syn). The resultant clinical profile varies for PD patients without GBA mutations. The current study aimed to identify the proteomic targets involved in the pathogenic pathways leading to the differential clinical presentation of GBA-associated PD. CSF samples (n = 32) were obtained from PD patients with GBA mutations (n = 22), PD patients without GBA mutations (n = 7), and healthy controls that were carriers of GBA mutations (n = 3). All samples were subjected to in-gel tryptic digestion followed by the construction of the spectral library and quantitative SWATH-based analysis. CSF α-Syn levels were reduced in both PDIdiopathic and PDGBA cases. Our SWATH-based mass spectrometric analysis detected 363 proteins involved in immune response, stress response, and cell signaling in various groups. Intergroup analysis showed that 52 proteins were significantly up- or downregulated in various groups. Of these 52 targets, 20 proteins were significantly altered in PDGBA cases only while 2 showed different levels in PDIdiopathic patients. Our results show that the levels of several pathologically relevant proteins, including Contactin-1, Selenium-binding protein 1, Adhesion G Protein-Coupled Receptor, and Apolipoprotein E are significantly different among the sporadic and genetic variants of PD and hint at aggravated synaptic damage, oxidative stress, neuronal loss, and aggregation of α-Syn in PDGBA cases.
Keyword(s): Glucosylceramidase: metabolism (MeSH) ; Humans (MeSH) ; Glucosylceramidase: genetics (MeSH) ; Proteome (MeSH) ; Parkinson Disease: genetics (MeSH) ; Proteomics (MeSH) ; Mass Spectrometry (MeSH) ; Parkinson Disease: metabolism (MeSH) ; Cerebrospinal Fluid: chemistry (MeSH) ; Cerebrospinal Fluid: metabolism (MeSH) ; α-synuclein ; CSF ; SWATH ; proteomics ; α-synuclein ; β-glucocerebrosidase ; Glucosylceramidase ; Proteome ; β-glucocerebrosidase
; 
; 
; 
; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
PDF
PDF (PDFA)